Cabaletta Bio (CABA) Other Non-Current Assets (2019 - 2026)
Cabaletta Bio (CABA) posted quarterly Other Non-Current Assets of $5.2 million for Q4 2025, up 124.99% year-over-year from $2.3 million in Q4 2024, and up 43.03% quarter-over-quarter from $3.6 million in Q3 2025.
Cabaletta Bio (CABA) Other Non-Current Assets (2019 - 2026) Analysis & Trends
Cabaletta Bio's Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $5.2 million for Q4 2025.
- In Q4 2025, Other Non-Current Assets rose 124.99% year-over-year to $5.2 million; the TTM figure through Dec 2025 stood at $5.2 million (up 124.99% YoY), while the FY2025 annual figure was $5.2 million, up 124.99% from the prior year.
- Other Non-Current Assets for Q4 2025 stood at $5.2 million, up from $3.6 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $5.2 million in Q4 2025, with the low at $300000.0 in Q1 2021.
- The 5-year median for Other Non-Current Assets is $984500.0 (2022), against an average of $1.6 million.
- The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets plunged 41.02% in 2023, then surged 307.57% in 2024.
- Cabaletta Bio's Other Non-Current Assets stood at $357000.0 in 2021, then surged by 58.26% to $565000.0 in 2022, then surged by 202.48% to $1.7 million in 2023, then jumped by 34.17% to $2.3 million in 2024, then surged by 124.99% to $5.2 million in 2025.
- Business Quant data shows CABA's Other Non-Current Assets at $5.2 million in Q4 2025, $3.6 million in Q3 2025, and $2.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 124.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 42.45 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 109.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 18,237.65 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 62.96 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 65.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 104.44 Mn |
| 10 | Cabaletta Bio | 466.25 Mn | 466.25 Mn | - | 6.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.21 Mn |
| Dec 31, 2025 | 5.16 Mn |
| Sep 30, 2025 | 3.61 Mn |
| Jun 30, 2025 | 2.50 Mn |
| Mar 31, 2025 | 2.37 Mn |
| Dec 31, 2024 | 2.29 Mn |
| Sep 30, 2024 | 2.48 Mn |
| Jun 30, 2024 | 2.25 Mn |
| Mar 31, 2024 | 2.37 Mn |
| Dec 31, 2023 | 1.71 Mn |
| Sep 30, 2023 | 984,000.00 |
| Jun 30, 2023 | 685,000.00 |
| Mar 31, 2023 | 581,000.00 |
| Dec 31, 2022 | 565,000.00 |
| Sep 30, 2022 | 689,000.00 |
| Jun 30, 2022 | 965,000.00 |
| Mar 31, 2022 | 985,000.00 |
| Dec 31, 2021 | 357,000.00 |
| Sep 30, 2021 | 324,000.00 |
| Jun 30, 2021 | 318,000.00 |